Uterine Cancer

Estrogen for Survivors of Uterine Cancer? A New Study Will Resolve Debate

Published in Cancer Weekly, May 26th, 1997

The first large, national study of estrogen replacement therapy (ERT) for women who have had cancer of the uterus will start enrolling patients this summer, researchers announced at the annual meeting of The American College of Obstetricians and Gynecologists (ACOG) in Las Vegas.

The study is designed to resolve the current controversy over the safety of estrogen replacement for survivors of uterine, or endometrial, cancer.

The ERT Study is being sponsored by the National Cancer Institute (NCI) and organized by the Gynecologic Oncology Group (GOG), a program of ACOG. GOG is one of 11 cooperative trial groups -- networks of medical centers that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-05-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry